Search Orphan Drug Designations and Approvals
-
Generic Name: | Sintilimab |
---|---|
Date Designated: | 04/14/2020 |
Orphan Designation: | Treatment of esophageal cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Innovent Biologics (Suzhou) Co. Ltd 168 Dongping Street Suzhou Industrial Park, Jiangsu Province China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-